Internal Medicine Alert – November 30, 2016
November 30, 2016
View Issues
-
Statins Associated with Lower Parkinson’s Risk in Diabetics
In approximately 50,000 individuals with Parkinson’s disease and diabetes, identified from a National Health Insurance database in Taiwan, statin use was dose-dependently associated with lower risk of Parkinson’s disease.
-
Changing Gut Microbiota to Prevent Type 2 Diabetes
The long-term consumption of a healthy diet, such as the Mediterranean diet or low-fat/high complex carbohydrate diets, may exert a protective effect on the development of type 2 diabetes by changing the gut microbiota.
-
Warning: Reactivation of Hepatitis B Virus Coinfection During Treatment of Chronic Hepatitis C Virus Infection
Prior to initiation of hepatitis C virus treatment with direct-acting antivirals, patients should be screened for hepatitis B virus coinfection.
-
Eteplirsen Injection (Exondys 51)
Eteplirsen is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who present with confirmed mutation of the DMD gene that is amenable to exon 51 skipping.
-
Clinical Briefs
In this section: treating refractory chronic pruritus, accelerating weight loss with technology, and lowering uric acid in gout patients.